SUTRO BIOPHARMA ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 TRIAL OF STRO-006, A NEXT-GENERATION ITGB6-TARGETING ADC, IN ADVANCED SOLID TUMORS

Reuters · 2d ago

Please log in to view news